Stay updated on Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision labels were updated: 'Revision: v3.4.3' added and 'Revision: v3.4.2' removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFallopian tube cancer was added to the conditions section, and the Genetic and Rare Diseases Information Center resource was added under Resources.SummaryDifference0.1%

- Check34 days agoChange DetectedThere is a new revision label 'Revision: v3.4.2' on the page and the previous notice about government funding status and operating updates has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded a 'Show glossary' option and updated QC-related fields (Last Update Submitted that Met QC Criteria) and policy text (No FEAR Act Data) with a new revision tag (v3.4.0). Deletions remove the prior QC wording (Last Update Submitted that met QC Criteria; No FEAR Act data; v3.3.4); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a version update from v3.3.3 to v3.3.4 with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Weekly Tisotumab Vedotin in Platinum-Resistant Ovarian Cancer Clinical Trial page.